Patent holdings for IPC class A61K 31/00

Total number of patents in this class: 7802

10-year publication summary

541
595
535
496
541
498
537
518
518
236
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Inserm (institut National de La Sante et de La Recherche Medicale)
3367
100
Novartis AG
10856
75
The Regents of the University of California
19887
70
Centre National de La Recherche Scientifique
10418
48
Institut National de La Sante et de La Recherche Medicale (inserm)
2809
48
The Johns Hopkins University
5662
47
The Board of Trustees of the Leland Stanford Junior University
6403
42
Boehringer Ingelheim International GmbH
4665
33
Genentech, Inc.
3972
28
F. Hoffmann-La Roche AG
7930
26
AstraZeneca AB
2923
26
Duke University
3065
26
Gilead Sciences, Inc.
2036
26
LTS Lohmann Therapie-Systeme AG
692
26
Massachusetts Institute of Technology
10041
25
Cellixbio Private Limited
155
25
Vanda Pharmaceuticals, Inc.
355
25
Buzzelet Development and Technologies Ltd
94
25
Centre National de La Recherche Scientifique (cnrs)
3121
25
Janssen Pharmaceutica N.V.
3392
23
Other owners 7033